loadpatents
name:-0.028550148010254
name:-0.018378973007202
name:-0.00038504600524902
RENSHAW; Perry F. Patent Filings

RENSHAW; Perry F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for RENSHAW; Perry F..The latest application filed is for "diagnosis of affective disorders using magnetic resonance spectroscopy neuroimaging".

Company Profile
0.18.26
  • RENSHAW; Perry F. - Salt Lake City UT
  • Renshaw; Perry F. - Bedford MA US
  • Renshaw; Perry F. - Arlington MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Diagnosis Of Affective Disorders Using Magnetic Resonance Spectroscopy Neuroimaging
App 20170209084 - RENSHAW; Perry F. ;   et al.
2017-07-27
Brain phosphorus spectroscopy in bipolar disorder
Grant 8,897,854 - Renshaw , et al. November 25, 2
2014-11-25
Depression Disorder Therapeutics With Creatine Analogs
App 20130324609 - Renshaw; Perry F. ;   et al.
2013-12-05
Compounds for the treatment of psychiatric or substance abuse disorders
Grant 8,575,219 - Renshaw November 5, 2
2013-11-05
Methods For The Treatment Of Psychiatric Disorders
App 20130281410 - Renshaw; Perry F.
2013-10-24
Use of secretin in treatments of disorders associated with the amygdala
Grant 8,524,665 - Yurgelun-Todd , et al. September 3, 2
2013-09-03
Brain Phosphorus Spectroscopy In Bipolar Disorder
App 20130123605 - RENSHAW; Perry F. ;   et al.
2013-05-16
Compounds for the treatment of psychiatric or substance abuse disorders
Grant 8,030,294 - Renshaw October 4, 2
2011-10-04
Compounds for the treatment of marihuana dependence, withdrawal, and usage
Grant 7,947,661 - Lukas , et al. May 24, 2
2011-05-24
Compounds for the treatment of psychiatric or substance abuse disorders
Grant 7,863,254 - Renshaw January 4, 2
2011-01-04
Methods Of Treating Psychiatric, Substance Abuse, And Other Disorders Using Combinations Containing Omega-3 Fatty Acids
App 20100197628 - Renshaw; Perry F. ;   et al.
2010-08-05
Compounds for the Treatment of Marihuana Dependence, Withdrawal, and Usage
App 20080300214 - Lukas; Scott E. ;   et al.
2008-12-04
Compounds For The Treatment Of Psychiatric Or Substance Abuse Disorders
App 20080132472 - Renshaw; Perry F.
2008-06-05
Magnetic field stimulation techniques
Grant 7,282,021 - Rohan , et al. October 16, 2
2007-10-16
Use of secretin in treatments of disorders associated with the amygdala
App 20070185018 - Yurgelun-Todd; Deborah A. ;   et al.
2007-08-09
Magnetic field stimulation techniques
App 20060264691 - Rohan; Michael L. ;   et al.
2006-11-23
Magnetic field stimulation techniques
Grant 7,033,312 - Rohan , et al. April 25, 2
2006-04-25
Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant
App 20060039890 - Renshaw; Perry F. ;   et al.
2006-02-23
Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids
App 20050129710 - Renshaw, Perry F. ;   et al.
2005-06-16
Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
App 20050113449 - Renshaw, Perry F.
2005-05-26
Method for providing optimal drug dosage
Grant 6,898,455 - Anderson , et al. May 24, 2
2005-05-24
Compounds for the normalization of the sleep/wake cycle
App 20040176316 - Renshaw, Perry F. ;   et al.
2004-09-09
Purinergic antagonists for treating depression
App 20040029841 - Renshaw, Perry F.
2004-02-12
Magnetic field stimulation techniques
App 20040010177 - Rohan, Michael L. ;   et al.
2004-01-15
Compounds for the treatment of psychiatric or substance abuse disorders
App 20030220291 - Renshaw, Perry F.
2003-11-27
Method for assessing cortical response to blue light
Grant 6,630,127 - Renshaw , et al. October 7, 2
2003-10-07
Two-dimensional MR spectroscopy techniques
Grant 6,617,169 - Ke , et al. September 9, 2
2003-09-09
Cholesterol-lowering agents as treatment for psychological and cognitive disorders
App 20030144341 - Renshaw, Perry F. ;   et al.
2003-07-31
Magnetic field stimulation techniques
Grant 6,572,528 - Rohan , et al. June 3, 2
2003-06-03
Method for providing optimal drug dosage
App 20020193684 - Anderson, Carl M. ;   et al.
2002-12-19
Cholesterol-lowering agents as treatment for psychological and cognitive disorders
App 20020173535 - Renshaw, Perry F. ;   et al.
2002-11-21
Magnetic field stimulation techniques
App 20020169355 - Rohan, Michael L. ;   et al.
2002-11-14
Two- dimensional MR spectroscopy techniques
App 20020142367 - Ke, Yong ;   et al.
2002-10-03
Use of magnetic resonance imaging in diagnosis of membrane fluidity-related disorders
App 20020102211 - Renshaw, Perry F. ;   et al.
2002-08-01
Method and apparatus for detecting mental disorders
Grant 6,400,978 - Teicher , et al. June 4, 2
2002-06-04
Method for assessing cortical response to blue light
App 20020034472 - Renshaw, Perry F. ;   et al.
2002-03-21
Compounds for the treatment of psychiatric or substance abuse disorders
App 20020019364 - Renshaw, Perry F.
2002-02-14
Phased array echoplanar imaging system for fMRI
Grant 6,104,943 - Frederick , et al. August 15, 2
2000-08-15
Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure
Grant 5,958,896 - Renshaw , et al. September 28, 1
1999-09-28
Registration of image data
Grant 5,850,486 - Maas, III , et al. December 15, 1
1998-12-15
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed